Metabolic syndrome is linked to changes in the gut microbiota and damage to the gut barrier, but the microbial molecules involved are still being worked out. Now, a study in mice shows that gut bacteria-derived vitamin B5 may protect against metabolic syndrome by strengthening the intestinal barrier and reducing inflammation.

The findings, published in Cell Host & Microbe, suggest that targeting gut bacteria that produce vitamin B5, or delivering vitamin B5 directly to the gut, could be a new way to prevent or treat metabolic syndrome.

Vitamin B5 is needed to produce coenzyme A, a molecule involved in many cellular processes. However, our body cannot make the vitamin and obtains it from food and gut microbes. Although some gut bacteria are known to make vitamin B5, its local effects in the gut have received little attention.

So, researchers led by Zichen Luo at Nanjing University of Chinese Medicine in China compared stool metabolites and gut microbes in people with and without metabolic syndrome and in mice fed normal or high-fat diets.

Lowering inflammation

Vitamin B5 was lower in the stool of people and mice with metabolic problems. Lower levels were associated with greater insulin resistance, higher body weight, higher blood sugar and fatty molecules, and more evidence that the gut barrier was leaking. 

Giving vitamin B5 to mice on a high-fat diet reduced weight gain and improved their responses to glucose and insulin. It also improved blood-fat measures and reduced fat accumulation in the liver. In the gut, vitamin B5 increased proteins that seal neighboring intestinal cells together and lowered inflammatory markers in the blood.

In miniature colon tissues called organoids, vitamin B5 made these cell layers form a stronger barrier and become more resistant to damage caused by inflammatory molecules.

Barrier strengthening

Three bacterial species—Bacteroides fragilis, Bacteroides uniformis, and Bacteroides intestinalis—tracked with stool vitamin B5 levels, and giving them to mice fed a high-fat diet raised gut vitamin B5 and improved glucose control. But when B. fragilis was engineered so it could not make the vitamin, those benefits largely disappeared.

The researchers also found that a carbohydrate from Platycodon grandiflorum, an edible plant, increased the abundance of Bacteroides and raised stool vitamin B5 levels in mice. It also improved glucose and insulin responses, reduced inflammation, and increased intestinal barrier proteins. 

The work, the authors say, “not only expands current knowledge of microbiota-derived B vitamins in maintaining host health but also provides a potential strategy for restoring barrier function and mitigating [metabolic syndrome].”